| 763828 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
533 An open label Phase IA/IB study for safety, pharmacokinetics (PK), and efficacy of ONC 392 as a single agent and in combination with Pembrolizumab in advanced solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.533 |
Zheng Pan, He Kun, Liu Yang |
| 763827 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
291 Dual-specific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 restore anti-tumor immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.291 |
Couillault Coline, Srinivasamani Anupallavi, Hedge Shweta, Liu Qinying, Jaiswal Ashwin, Zha Dongxing, Curran Michael |
| 763826 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
184 Adoptive T cell therapies targeting common p53 neoantigens in human solid cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.184 |
Kim Peter, Rosenberg Steven, Vale Nolan |
| 763825 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.617 |
Tsao Li-Chung, Hartman Zachary |
| 763824 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
167 High-efficiency capture of anti-tumor neoantigen-reactive T cell receptors from tumor digest |
2021-11-01 |
10.1136/jitc-2021-sitc2021.167 |
Chatani Praveen, Lowery Frank, Parikh Neilesh, Yossef Rami, Hill Victoria, Yu Zhiya, Prickett Todd, Gartner Jared, Paria Biman, Ray Satyajit, Florentin Maria, Robbins Paul, Krishna Sri, Rosenberg Steven |
| 763823 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
106 Treatment with CC-99282 enhances antitumor function of the anti-CD19 CAR T cell therapy lisocabtagene maraleucel (liso-cel) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.106 |
Brahmandam Archana, Qin Jim, Kim Susan, Jiang Yue, Barajas Brook, Carrancio Soraya, Peiser Leanne |
| 763822 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
370 Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial |
2021-11-01 |
10.1136/jitc-2021-sitc2021.370 |
Pothuri Bhavana, Berton Dominique, Moreno Victor, Oaknin Ana, Trigo Perez Jose Manuel, Curigliano Giuseppe, Ellard Susan, Pikiel Joanna, Banerjee Susana, Barretina-Ginesta Maria-Pilar, Miller Rowan, Tinker Anna, Jewell Andrea, Plummer Ruth, Joly Florence, Veneris Jennifer, Duan Tao, Andre Thierry |
| 763821 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials |
2021-11-01 |
10.1136/jitc-2021-sitc2021.390 |
Johnson Melissa, Sacher Adrian, Butler Marcus, Zarour Hassane, Weber Jeffrey, Garon Edward, Carbone David, Dhar Arindam, Messina Cristina, Patel Roma, Blouch Kristin, Hoos Axel, Martin Anne-Marie |
| 763820 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
35 Chemokine-driven spatial organization of immune cell microaggregates marks oropharyngeal squamous cell carcinomas containing tumor-specific T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.035 |
Abdulrahman Ziena, Santegoets Saskia, Sturm Gregor, Charoentong Pornpimol, Ijsselsteijn Marieke, Somarakis Antonios, Höllt Thomas, Finotello Francesca, Trajanoski Zlatko, Egmond Sylvia van, Mustafa Dana, Welters Marij, Miranda Noel de, Burg Sjoerd van der |
| 763819 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
361 Heterogeneity of PD-1hi T cells associates with response to PD-1 blockade in hepatocellular carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.361 |
Magen Assaf, Magen Assaf, Hamon Pauline, Schwartz Myron, Marron Thomas, Kamphorst Alice, Merad Miriam |
